Spectrum Asset Management (California)’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-37,071
Closed -$642K 90
2024
Q4
$642K Sell
37,071
-820
-2% -$15.8K 0.29% 62
2024
Q3
$702K Sell
37,891
-1,100
-3% -$22.1K 0.3% 60
2024
Q2
$791K Buy
+38,991
New +$690K 0.37% 53
2018
Q3
Sell
-8,825
Closed -$1.11M 90
2018
Q2
$1.11M Hold
8,825
0.99% 24
2018
Q1
$1.08M Buy
+8,825
New +$977K 0.95% 24
2017
Q1
Sell
-9,060
Closed -$1.09M 68
2016
Q4
$1.09M Sell
9,060
-410
-4% -$45.4K 1.05% 20
2016
Q3
$1.06M Sell
9,470
-220
-2% -$25.3K 1.15% 20
2016
Q2
$1.2M Buy
+9,690
New +$1.17M 1.42% 17

Other funds holding CLB

Spectrum Asset Management (California)'s CLB Position: Q1 2025 in Review

Spectrum Asset Management (California) sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 37,071 shares — an estimated $642K sold.

Spectrum Asset Management (California) first reported a position in CLB in Q2 2016 and held it in 8 quarters. The position peaked at $1.2M in Q2 2016. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

  • Spectrum Asset Management (California) reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
  • Spectrum Asset Management (California) sold 37,071 Core Laboratories shares in Q1 2025, an estimated $642K.
  • Spectrum Asset Management (California) first reported a position in Core Laboratories in Q2 2016 and held it in 8 quarters.
  • Spectrum Asset Management (California)'s Core Laboratories position peaked at $1.2M in Q2 2016.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Spectrum Asset Management (California)'s 13F filing for Q1 2025, filed 16 Apr 2025.